Latest Careteq News

Page 1 of 2
Careteq will challenge the Australian Taxation Office’s rejection of its objections to amended assessments covering three financial years. The healthtech company says its R&D claims remain valid, but the dispute’s financial exposure and resolution timetable have not been disclosed.
Victor Sage
Victor Sage
20 Nov 2026
Careteq Limited (ASX: CTQ) reported a $398K net loss for FY26 amid a strategic reset that included selling its Embedded Health Solutions business and repaying all debt. The company now pivots fully to growing its HMR Referrals platform with $3.19 million cash on hand.
Ada Torres
Ada Torres
27 Aug 2026
Careteq Limited (ASX: CTQ) has confirmed it will maintain its ASX listing after selling its Embedded Health Solutions subsidiary, shifting its strategic focus entirely to its HMR Referrals platform. The company reported positive operating cash flow in the March quarter and outlined plans to expand its pharmacist and GP networks while exploring AI and adjacent healthcare opportunities.
Ada Torres
Ada Torres
23 July 2026
Careteq Limited’s strategic investor Antanas Guoga has converted all his convertible notes into shares, wiping out the company’s convertible debt and simplifying its capital structure ahead of its AI healthtech growth push.
Ada Torres
Ada Torres
4 June 2026
Careteq Limited has cleared $125,000 in director and company secretary loans a month ahead of schedule, using proceeds from a recent $2.2 million capital raising. This move strengthens the healthtech firm’s balance sheet and removes related-party debt ahead of maturity.
Ada Torres
Ada Torres
6 May 2026
Careteq Limited has finalised the sale of its Embedded Health Solutions subsidiary for approximately $5 million, repaid related vendor loans, and plans to concentrate on growing its HMR Referrals platform amid ongoing regulatory and compliance considerations.
Ada Torres
Ada Torres
9 Apr 2026
Careteq Limited has successfully raised $2.2 million through a two-tranche share placement, with a significant portion subject to upcoming shareholder approval. The funds aim to support project acquisitions, debt reduction, and working capital needs.
Ada Torres
Ada Torres
11 Mar 2026
Careteq Limited reported a widening half-year loss with revenues down 18%, announcing plans to sell its Embedded Health Solutions business to strengthen its balance sheet and focus on its HMR Referral platform.
Ada Torres
Ada Torres
26 Feb 2026
Careteq Limited has agreed to sell its Embedded Health Solutions business for $5 million, aiming to strengthen its balance sheet and focus on expanding its home medication review platform amid ongoing tax disputes.
Ada Torres
Ada Torres
6 Feb 2026
Careteq Limited reported a disciplined operating cash flow in Q2 FY26 with strong growth in its Embedded Health Solutions segment and ongoing resolution of an ATO tax incentive dispute.
Ada Torres
Ada Torres
30 Jan 2026
Careteq Limited signals progress on its 1-System platform integration with a planned Q3 FY26 restart, while Embedded Health Solutions expands aged care contracts and the company navigates a significant ATO R&D tax objection.
Ada Torres
Ada Torres
30 Oct 2025
Careteq Limited has returned to profitability in FY25, reporting a 5.4% revenue increase and a 171% jump in underlying EBITDA, driven by strategic divestments and acquisitions.
Ada Torres
Ada Torres
29 Aug 2025

Browse the archive

Full archive